Feb. 24 (UPI) -- Biotech company Moderna said Thursday that it expects to make almost $20 billion this year from sales of its COVID-19 vaccine -- the only product that it has on the market.
Moderna said in its earnings report that it generated $4.9 billion in the final quarter of 2021 and sold almost $18 billion worth of the vaccine for all of last year, its first full year of selling the coronavirus shot.